Press Releases
Key exhibitors and industry partners show strong support for MEDICAL MANUFACTURING ASIA 2016
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform Established as Asia’s leading exhibition for the medical technology, medical manufacturing processes and related sectors, MEDICAL MANUFACTURING ASIA...
Press Releases
FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood
Hologic, Inc. and Grifols market-leading partners committed to blood safety - announced that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther system under the...
Press Releases
Allergan plc announces data at ASM Microbe Highlight In Vitro Antimicrobial Activity of AVYCAZ
Allergan plc committed to developing new treatment options for infectious diseases, today presented new data highlighting the in vitro activity of AVYCAZ® against several species of Gram-negative pathogens, including certain strains of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae and Pseudomonas...
Press Releases
Medipak Systems Open House at the new premises of Dividella AG
Dividella AG, a Medipak Systems company, welcomed guests to the two-day pharma event in its new premises in Grabs, Switzerland. As part of the extension of its capacity, Dividella has leased additional premises in the adjacent...
Press Releases
Quotient Clinical hosts formulation development and drug delivery seminar series
Quotient Clinical, the Translational Pharmaceutics company, is holding a series of formulation development and drug delivery seminars this June and July. The seminars will take place at major life science hubs in the UK and USA,...
Press Releases
Teva Pharmaceutical Inc suspends marketing for Zecuity in US
Teva Pharmaceutical Industries, Ltd. announced that it will voluntarily suspend sales, marketing and distribution of ZECUITY® (sumatriptan iontophoretic transdermal system). Teva has received post-marketing reports of application site reactions described as burns and scars in patients...
Press Releases
FDA Accepted Charleston Laboratories, Inc. and Daiichi Sankyo’s New Drug Application (NDA) for CL-108
Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. announced that the U.S. FDA has accepted for review the New Drug Application (NDA) for CL-108 for the relief of moderate to severe pain while preventing or reducing the associated opioid-induced nausea...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















